Clinical trials
Completed Paresis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
181 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 14 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 10 |
| 2016 | 13 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 19 |
| 2020 | 10 |
| 2021 | 14 |
| 2022 | 13 |
| 2023 | 10 |
| 2024 | 11 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 181 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MetroHealth Medical Center | 7 |
| Ohio State University | 7 |
| University of Alabama at Birmingham | 5 |
| VA Office of Research and Development | 5 |
| Medical University of South Carolina | 4 |
| IRCCS San Raffaele Roma | 3 |
| Pamukkale University | 3 |
| Universitat Pompeu Fabra | 3 |
| Ahmed Alshimy | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Paresis | 181 |
| Stroke | 131 |
| Hemiplegia | 24 |
| Cerebral Palsy | 12 |
| Ischemic Stroke | 11 |
| Muscle Spasticity | 8 |
| Gait Disorders, Neurologic | 7 |
| Cerebrovascular Disorders | 5 |
| Hemorrhagic Stroke | 5 |
| Mobility Limitation | 5 |
Trials
Showing 1 to 25 of 181. Each trial links to its page on Pharma Observatory.
81 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.